Recently Viewed
Clear All
Bidding Date
11-Dec-2024 to
13-Dec-2024
Issue Size
₹3042.62 Cr
Price Band
₹522 to ₹549
Allotment date
16-Dec-2024
Listing date
18-Dec-2024
Lot size
27
No. of shares
5,54,21,123
Fresh issue/OFS
₹950 Cr/₹2092.62 Cr
Established in 1999, Sai Life Sciences Ltd operates as a CRDMO offering integrated services across the pharmaceutical value chain. It specializes in two primary areas: (1) Contract Research (CRO) and (2) Contract Development and Manufacturing (CDMO). In CRO, it provides end-to-end discovery services, including target identification, hit identification, biological assay development, medicinal chemistry, synthetic chemistry, and drug metabolism and pharmacokinetics (DMPK). In CDMO, the company focuses on the development, scaling, and manufacturing of active pharmaceutical ingredients (APIs) and intermediates, supporting both clinical and commercial supplies. The company also operates across multiple therapeutic areas, such as oncology, CNS disorders, inflammation, antivirals, and rare diseases.
Read our in-depth analysis of the Sai Life Sciences Ltd IPO Here 
Category
Status
QIBs
30.9x
NIIs
4.9x
Retail
1.4x
Others
--
Total
10.3x
| Name | Price Band (Rs) | Bidding Date |
|---|---|---|
| Novus Loyalty | 139 - 146 | 17-Mar-2026 to 20-Mar-2026 |
| Powerica | 375 - 395 | 24-Mar-2026 to 27-Mar-2026 |
| Amir Chand Jagdish Kumar (Exports) | 201 - 212 | 24-Mar-2026 to 27-Mar-2026 |
| Highness Microelectronics | 114 - 120 | 24-Mar-2026 to 27-Mar-2026 |
The issue size of Sai Life Sciences is ₹3,042.62 Cr.
Sai Life Sciences falls into Biotechnology & R&D industry.
The Sai Life Sciences IPO will be listed on both NSE and BSE.
The open and close dates for the Sai Life Sciences are 11-Dec-2024 & 13-Dec-2024.
The price band for the Sai Life Sciences ipo is ₹522 to ₹549
The listing date of Sai Life Sciences IPO is 18-Dec-2024.
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
Sai Life Sciences total subscription ratio is 10.3X.
Key financial of the Sai Life Sciences are:
| Sai Life Sciences | FY-24 | FY-23 | FY-22 |
|---|---|---|---|
| Revenue (₹ Cr) | 1465.18 | 1217.14 | 869.59 |
| EBIT (₹ Cr) | 167.7 | 69.47 | 34.73 |
| Proft after Tax (₹ Cr) | 82.81 | 9.99 | 6.23 |
| Debt (₹ Cr) | 710.16 | 699.23 | 751.32 |
| Net Worth (₹ Cr) | 975.14 | 888.09 | 878.57 |
| RoE (%) | 8.49 | 1.12 | 0.71 |
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
